Soleno Therapeutics Inc Stock

$79.15

1.31% yesterday

Nasdaq, Jun 13, 10:00 pm CET

ISIN

US8342032005

Symbol

SLNO

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Medical specialties

Overview Dividends Analysts Charts News Strategies

Soleno Therapeutics Inc Stock price

$79.15

+49.75 169.22% 5Y

Nasdaq, Closing price Fri, Jun 13 2025

-1.05 1.31%

ISIN

US8342032005

Symbol

SLNO

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Medical specialties

Key metrics

Market capitalization	$3.99b
Enterprise Value	$3.75b
P/E (TTM) P/E ratio	negative
EV/FCF (TTM) EV/FCF	negative
P/B ratio (TTM) P/B ratio	16.72
Revenue (TTM) Revenue	$0.00
EBIT (operating result TTM) EBIT	$-210.00m
Free Cash Flow (TTM) Free Cash Flow	$-89.22m
Cash position	$289.95m
EPS (TTM) EPS	$-4.32
P/E forward	negative
P/S forward	85.04
EV/Sales forward	79.92
Short interest	9.11%

As a Free StocksGuide user, you can view scores for all 6,847 stocks worldwide.

Get Started for Free Today

Soleno Therapeutics Inc Stock Analysis

Unlock Scores for Free

??

9 Analysts have issued a Soleno Therapeutics Inc forecast:

9x Buy

100%

More details on Analyst Estimates Including Price Targets

9 Analysts have issued a Soleno Therapeutics Inc forecast:

Buy

100%

Analyst Estimates with Stock Price Targets

Financial data from Soleno Therapeutics Inc

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Mar '25		+/- %
Revenue	- -	- 100%
- Direct Costs	- -	- -
Gross Profit	- -	- -
- Selling and Administrative Expenses	126 126	560% 560% -
- Research and Development Expense	77 77	125% 125% -
EBITDA	-208 -208	286% 286% -
- Depreciation and Amortization	2 2	2% 2% -
EBIT (Operating Income) EBIT	-210 -210	276% 276% -
Net Profit	-199 -199	285% 285% -

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Soleno Therapeutics Inc Stock News

Neutral

Schaeffers Research

●

2 days ago

These 24 Stocks Are Ripe for a Short Squeeze

With the way negative stock market sentiment has piled up recently, short squeezes have generated some massive returns.

Neutral

GlobeNewsWire

●

23 days ago

Soleno Therapeutics Announces Submission and EMA Validation of Marketing Authorization Application for Diazoxide Choline Prolonged-Release Tablets for the Treatment of Hyperphagia in Patients with Prader-Willi Syndrome

REDWOOD CITY, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that Soleno's Marketing Authorization Application (MAA) seeking regulatory approval of Diazoxide Choline Prolonged-Release Tablets (previously referred to as DCCR) for the treatment...

Neutral

GlobeNewsWire

●

25 days ago

Soleno Therapeutics Announces Data Presentation Showing that Resumption of Treatment with VYKAT(TM) XR after a Randomized Withdrawal Period was Associated with Significant Improvements in Hyperphagia and Behavioral Symptoms in Participants with Prader-Willi Syndrome

REDWOOD CITY, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced data presented from its clinical development program of VYKAT™ XR (diazoxide choline) extended-release tablets, previously referred to as DCCR, at the Pediatric Endocrine Society (PES) Annua...

More Soleno Therapeutics Inc News

Company Profile

Soleno Therapeutics, Inc. engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. The company focuses on the treatment of metabolic and neurobehavioral disorder. It offers its lead candidate, Diazoxide Choline Controlled-Release (DCCR), an oral tablet for the treatment of Prader-Willi Syndrome (PWS). The company was founded on August 25, 1999 and is headquartered in Redwood City, CA.

Head office	United States
CEO	Anish Bhatnagar
Employees	92
Founded	1999
Website	soleno.life

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now